Surrozen, Inc.

Historical 13F Holders

Symbol
SRZN
CUSIP
86889P208
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 86889P208 since 12/18/2024, newest first.

Filer % of Class Filed
Boxer Capital Management, LLC 13G/A Amendment 2
11.6% 10/7/2026
Event 9/30/2026
Commodore Capital LP 13G
7.5% 10/1/2026
Event 9/24/2026
Boxer Capital Management, LLC 13G/A Amendment 1
8.9% 8/14/2026
Event 6/30/2026
StemPoint Capital LP 13G
5.0% 8/14/2026
Event 6/30/2026
Braidwell LP 13G/A Amendment 1
3.9% 8/14/2026
Event 6/30/2026
5AM Partners VII, LLC 13G/A Amendment 2
7.8% 8/11/2026
Event 6/30/2026
TCG Crossover GP II, LLC 13G/A Amendment 2
9.9% 7/24/2026
Event 7/22/2026
Column Group III GP, LP 13D/A Amendment 6
29.3% 5/18/2026
Event 3/31/2026
5AM Partners VII, LLC 13G/A Amendment 1
9.5% 5/15/2026
Event 3/31/2026
Venrock Healthcare Capital Partners III, L.P. 13G/A Amendment 1
9.9% 5/15/2026
Event 3/31/2026
Boxer Capital Management, LLC 13G
6.7% 5/15/2026
Event 3/31/2026
TCG Crossover GP II, LLC 13G/A Amendment 1
12.7% 5/15/2026
Event 3/31/2026
Nantahala Capital Management, LLC 13G/A Amendment 3
2.1% 5/15/2026
Event 3/31/2026
StemPoint Capital LP 13G/A Amendment 5
4.5% 5/15/2026
Event 3/31/2026
Point72 Asset Management, L.P. 13G
5.4% 4/23/2026
Event 4/22/2026
RA Capital Management, L.P. 13G/A Amendment 2
9.2% 2/17/2026
Event 12/31/2025
StemPoint Capital LP 13G/A Amendment 4
7.0% 2/17/2026
Event 12/31/2025
Braidwell LP 13G
5.5% 2/17/2026
Event 12/31/2025
Stonepine Capital Management, LLC 13G/A Amendment 4
3.6% 2/13/2026
Event 12/31/2025
Column Group IV GP, LP 13D
11.6% 2/12/2026
Event 2/6/2026
Integrated Core Strategies (US) LLC 13G/A Amendment 1
8.5% 2/5/2026
Event 12/31/2025
TCG Crossover GP II, LLC 13G
11.4% 2/2/2026
Event 1/26/2026
Column Group III GP, LP 13D/A Amendment 5
35.1% 1/22/2026
Event 1/20/2026
Integrated Core Strategies (US) LLC 13G
6.6% 11/20/2025
Event 11/13/2025
Nantahala Capital Management, LLC 13G/A Amendment 2
5.2% 8/14/2025
Event 6/30/2025
StemPoint Capital LP 13G/A Amendment 3
11.4% 8/14/2025
Event 6/30/2025
Driehaus Capital Management LLC 13G/A Amendment 1 0.8% 8/14/2025
Event 6/30/2025
Stonepine Capital Management, LLC 13G/A Amendment 3
5.8% 8/13/2025
Event 6/30/2025
RA Capital Management, L.P. 13G/A Amendment 1
9.9% 5/15/2025
Event 3/31/2025
Nantahala Capital Partners Limited Partnership 13G/A Amendment 1 2.2% 5/15/2025
Event 3/31/2025
StemPoint Capital LP 13G/A Amendment 2
15.8% 5/15/2025
Event 3/31/2025
Perceptive Advisors LLC 13G/A Amendment 1
1.9% 5/15/2025
Event 3/31/2025
Driehaus Capital Management LLC 13G 6.3% 5/15/2025
Event 3/31/2025
Stonepine Capital Management, LLC 13G/A Amendment 2
9.9% 5/14/2025
Event 3/31/2025
Venrock Healthcare Capital Partners III, L.P. 13G
9.9% 4/2/2025
Event 3/26/2025
5AM Partners VII, LLC 13G
9.9% 4/2/2025
Event 3/26/2025
AI Biotechnology LLC 13G
9.9% 3/31/2025
Event 3/24/2025
Column Group III GP, LP 13D/A Amendment 4
34.0% 3/28/2025
Event 3/26/2025
Alyeska Investment Group, L.P. 13G/A Amendment 2
0.8% 2/14/2025
Event 12/31/2024
Nantahala Capital Management, LLC 13G/A Amendment 1
10.0% 2/14/2025
Event 12/31/2024
StemPoint Capital LP 13G/A Amendment 1
14.3% 2/14/2025
Event 12/31/2024
Perceptive Advisors LLC 13G
5.1% 2/14/2025
Event 12/31/2024
Regents of the University of California 13G 4.2% 1/28/2025
Event 12/31/2024
Nantahala Capital Partners Limited Partnership 13G 5.3% 11/14/2024
Event 9/30/2024
Nantahala Capital Management, LLC 13G
10.0% 11/14/2024
Event 9/30/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 1 62.0 $2.00 k
2026 Q2 71 10.7 M $275 M
2026 Q1 60 9.51 M $275 M
2025 Q4 55 7.27 M $156 M
2025 Q3 36 4.98 M $64.1 M
2025 Q2 32 4.66 M $41.7 M
2025 Q1 30 3.95 M $46.0 M
2024 Q4 24 1.66 M $23.8 M
2024 Q3 24 1.32 M $15.8 M
2024 Q2 25 1.52 M $16.6 M
2024 Q1 19 411 k $6.42 M
2023 Q4 20 448 k $4.21 M